List of Tables
Table 1. Global Targeted Therapy Drugs for Leukemia Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Targeted Therapy Drugs for Leukemia Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Targeted Therapy Drugs for Leukemia Market Competitive Situation by Manufacturers in 2025
Table 4. Global Targeted Therapy Drugs for Leukemia Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Targeted Therapy Drugs for Leukemia Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Targeted Therapy Drugs for Leukemia Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Targeted Therapy Drugs for Leukemia Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Targeted Therapy Drugs for Leukemia Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Targeted Therapy Drugs for Leukemia, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Targeted Therapy Drugs for Leukemia, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Targeted Therapy Drugs for Leukemia, Product Types and Applications
Table 12. Global Key Manufacturers of Targeted Therapy Drugs for Leukemia, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Targeted Therapy Drugs for Leukemia Companies by Tier (Tier 1, Tier 2, Tier 3), based on Targeted Therapy Drugs for Leukemia Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Targeted Therapy Drugs for Leukemia Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Targeted Therapy Drugs for Leukemia Sales by Region (Units), 2021–2026
Table 18. Global Targeted Therapy Drugs for Leukemia Sales Market Share by Region (2021–2026)
Table 19. Global Targeted Therapy Drugs for Leukemia Sales by Region (Units), 2027–2032
Table 20. Global Targeted Therapy Drugs for Leukemia Sales Market Share by Region (2027–2032)
Table 21. Global Targeted Therapy Drugs for Leukemia Revenue by Region (US$ Million), 2021–2026
Table 22. Global Targeted Therapy Drugs for Leukemia Revenue Market Share by Region (2021–2026)
Table 23. Global Targeted Therapy Drugs for Leukemia Revenue by Region (US$ Million), 2027–2032
Table 24. Global Targeted Therapy Drugs for Leukemia Revenue Market Share by Region (2027–2032)
Table 25. North America Targeted Therapy Drugs for Leukemia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Targeted Therapy Drugs for Leukemia Sales by Country (Units), 2021–2026
Table 27. North America Targeted Therapy Drugs for Leukemia Sales by Country (Units), 2027–2032
Table 28. North America Targeted Therapy Drugs for Leukemia Revenue by Country (US$ Million), 2021–2026
Table 29. North America Targeted Therapy Drugs for Leukemia Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Targeted Therapy Drugs for Leukemia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Targeted Therapy Drugs for Leukemia Sales by Country (Units), 2021–2026
Table 32. Europe Targeted Therapy Drugs for Leukemia Sales by Country (Units), 2027–2032
Table 33. Europe Targeted Therapy Drugs for Leukemia Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Targeted Therapy Drugs for Leukemia Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Targeted Therapy Drugs for Leukemia Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Targeted Therapy Drugs for Leukemia Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Targeted Therapy Drugs for Leukemia Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Targeted Therapy Drugs for Leukemia Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Targeted Therapy Drugs for Leukemia Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Targeted Therapy Drugs for Leukemia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Targeted Therapy Drugs for Leukemia Sales by Country (Units), 2021–2026
Table 42. Latin America Targeted Therapy Drugs for Leukemia Sales by Country (Units), 2027–2032
Table 43. Latin America Targeted Therapy Drugs for Leukemia Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Targeted Therapy Drugs for Leukemia Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Targeted Therapy Drugs for Leukemia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Targeted Therapy Drugs for Leukemia Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Targeted Therapy Drugs for Leukemia Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Targeted Therapy Drugs for Leukemia Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Targeted Therapy Drugs for Leukemia Revenue by Country (US$ Million), 2027–2032
Table 50. Global Targeted Therapy Drugs for Leukemia Sales (Units) by Type (2021–2026)
Table 51. Global Targeted Therapy Drugs for Leukemia Sales (Units) by Type (2027–2032)
Table 52. Global Targeted Therapy Drugs for Leukemia Sales Market Share by Type (2021–2026)
Table 53. Global Targeted Therapy Drugs for Leukemia Sales Market Share by Type (2027–2032)
Table 54. Global Targeted Therapy Drugs for Leukemia Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Targeted Therapy Drugs for Leukemia Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Targeted Therapy Drugs for Leukemia Revenue Market Share by Type (2021–2026)
Table 57. Global Targeted Therapy Drugs for Leukemia Revenue Market Share by Type (2027–2032)
Table 58. Global Targeted Therapy Drugs for Leukemia Price (US$/Unit) by Type (2021–2026)
Table 59. Global Targeted Therapy Drugs for Leukemia Price (US$/Unit) by Type (2027–2032)
Table 60. Global Targeted Therapy Drugs for Leukemia Sales (Units) by Application (2021–2026)
Table 61. Global Targeted Therapy Drugs for Leukemia Sales (Units) by Application (2027–2032)
Table 62. Global Targeted Therapy Drugs for Leukemia Sales Market Share by Application (2021–2026)
Table 63. Global Targeted Therapy Drugs for Leukemia Sales Market Share by Application (2027–2032)
Table 64. Global Targeted Therapy Drugs for Leukemia Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Targeted Therapy Drugs for Leukemia Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Targeted Therapy Drugs for Leukemia Revenue Market Share by Application (2021–2026)
Table 67. Global Targeted Therapy Drugs for Leukemia Revenue Market Share by Application (2027–2032)
Table 68. Global Targeted Therapy Drugs for Leukemia Price (US$/Unit) by Application (2021–2026)
Table 69. Global Targeted Therapy Drugs for Leukemia Price (US$/Unit) by Application (2027–2032)
Table 70. Novartis Pharms Company Information
Table 71. Novartis Pharms Description and Business Overview
Table 72. Novartis Pharms Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novartis Pharms Targeted Therapy Drugs for Leukemia Product
Table 74. Novartis Pharms Recent Developments/Updates
Table 75. Bristol-Myers Squibb Company Information
Table 76. Bristol-Myers Squibb Description and Business Overview
Table 77. Bristol-Myers Squibb Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bristol-Myers Squibb Targeted Therapy Drugs for Leukemia Product
Table 79. Bristol-Myers Squibb Recent Developments/Updates
Table 80. IL-Yang Pharms Company Information
Table 81. IL-Yang Pharms Description and Business Overview
Table 82. IL-Yang Pharms Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. IL-Yang Pharms Targeted Therapy Drugs for Leukemia Product
Table 84. IL-Yang Pharms Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Pfizer Targeted Therapy Drugs for Leukemia Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Takeda Oncology Company Information
Table 91. Takeda Oncology Description and Business Overview
Table 92. Takeda Oncology Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Takeda Oncology Targeted Therapy Drugs for Leukemia Product
Table 94. Takeda Oncology Recent Developments/Updates
Table 95. Johnson & Johnson Company Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Johnson & Johnson Targeted Therapy Drugs for Leukemia Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Gilead Sciences Company Information
Table 101. Gilead Sciences Description and Business Overview
Table 102. Gilead Sciences Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Gilead Sciences Targeted Therapy Drugs for Leukemia Product
Table 104. Gilead Sciences Recent Developments/Updates
Table 105. Abbvie Company Information
Table 106. Abbvie Description and Business Overview
Table 107. Abbvie Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Abbvie Targeted Therapy Drugs for Leukemia Product
Table 109. Abbvie Recent Developments/Updates
Table 110. Genentech Company Information
Table 111. Genentech Description and Business Overview
Table 112. Genentech Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Genentech Targeted Therapy Drugs for Leukemia Product
Table 114. Genentech Recent Developments/Updates
Table 115. Sanofi Company Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Sanofi Targeted Therapy Drugs for Leukemia Product
Table 119. Sanofi Recent Developments/Updates
Table 120. Amgen Company Information
Table 121. Amgen Description and Business Overview
Table 122. Amgen Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Amgen Targeted Therapy Drugs for Leukemia Product
Table 124. Amgen Recent Developments/Updates
Table 125. Roche Company Information
Table 126. Roche Description and Business Overview
Table 127. Roche Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Roche Targeted Therapy Drugs for Leukemia Product
Table 129. Roche Recent Developments/Updates
Table 130. GlaxoSmithKline Company Information
Table 131. GlaxoSmithKline Description and Business Overview
Table 132. GlaxoSmithKline Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. GlaxoSmithKline Targeted Therapy Drugs for Leukemia Product
Table 134. GlaxoSmithKline Recent Developments/Updates
Table 135. AstraZeneca Company Information
Table 136. AstraZeneca Description and Business Overview
Table 137. AstraZeneca Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. AstraZeneca Targeted Therapy Drugs for Leukemia Product
Table 139. AstraZeneca Recent Developments/Updates
Table 140. BeiGene Company Information
Table 141. BeiGene Description and Business Overview
Table 142. BeiGene Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. BeiGene Targeted Therapy Drugs for Leukemia Product
Table 144. BeiGene Recent Developments/Updates
Table 145. Eli Lilly Company Information
Table 146. Eli Lilly Description and Business Overview
Table 147. Eli Lilly Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Eli Lilly Targeted Therapy Drugs for Leukemia Product
Table 149. Eli Lilly Recent Developments/Updates
Table 150. Merck Company Information
Table 151. Merck Description and Business Overview
Table 152. Merck Targeted Therapy Drugs for Leukemia Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Merck Targeted Therapy Drugs for Leukemia Product
Table 154. Merck Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Targeted Therapy Drugs for Leukemia Distributors List
Table 158. Targeted Therapy Drugs for Leukemia Customers List
Table 159. Targeted Therapy Drugs for Leukemia Market Trends
Table 160. Targeted Therapy Drugs for Leukemia Market Drivers
Table 161. Targeted Therapy Drugs for Leukemia Market Challenges
Table 162. Targeted Therapy Drugs for Leukemia Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Targeted Therapy Drugs for Leukemia
Figure 2. Global Targeted Therapy Drugs for Leukemia Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Targeted Therapy Drugs for Leukemia Market Share by Type: 2025 & 2032
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Small-Molecule Drugs Product Picture
Figure 6. Global Targeted Therapy Drugs for Leukemia Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Targeted Therapy Drugs for Leukemia Market Share by Application: 2025 & 2032
Figure 8. Acute Myeloid Leukemia (AML)
Figure 9. Chronic Myeloid Leukemia (CML)
Figure 10. Acute Lymphoblastic Leukemia (ALL)
Figure 11. Chronic Lymphocytic Leukemia (CLL)
Figure 12. Global Targeted Therapy Drugs for Leukemia Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Targeted Therapy Drugs for Leukemia Market Size (US$ Million), 2021–2032
Figure 14. Global Targeted Therapy Drugs for Leukemia Sales (Units), 2021–2032
Figure 15. Global Targeted Therapy Drugs for Leukemia Average Price (US$/Unit), 2021–2032
Figure 16. Targeted Therapy Drugs for Leukemia Report Years Considered
Figure 17. Targeted Therapy Drugs for Leukemia Sales Share by Manufacturers in 2025
Figure 18. Global Targeted Therapy Drugs for Leukemia Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Targeted Therapy Drugs for Leukemia Players: Market Share by Revenue in Targeted Therapy Drugs for Leukemia in 2025
Figure 20. Targeted Therapy Drugs for Leukemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Targeted Therapy Drugs for Leukemia Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Targeted Therapy Drugs for Leukemia Sales Market Share by Country (2021–2032)
Figure 23. North America Targeted Therapy Drugs for Leukemia Revenue Market Share by Country (2021–2032)
Figure 24. United States Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Targeted Therapy Drugs for Leukemia Sales Market Share by Country (2021–2032)
Figure 27. Europe Targeted Therapy Drugs for Leukemia Revenue Market Share by Country (2021–2032)
Figure 28. Germany Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Targeted Therapy Drugs for Leukemia Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Targeted Therapy Drugs for Leukemia Revenue Market Share by Region (2021–2032)
Figure 35. China Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Targeted Therapy Drugs for Leukemia Sales Market Share by Country (2021–2032)
Figure 43. Latin America Targeted Therapy Drugs for Leukemia Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Targeted Therapy Drugs for Leukemia Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Targeted Therapy Drugs for Leukemia Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Targeted Therapy Drugs for Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Targeted Therapy Drugs for Leukemia by Type (2021–2032)
Figure 54. Global Revenue Market Share of Targeted Therapy Drugs for Leukemia by Type (2021–2032)
Figure 55. Global Targeted Therapy Drugs for Leukemia Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Targeted Therapy Drugs for Leukemia by Application (2021–2032)
Figure 57. Global Revenue Market Share of Targeted Therapy Drugs for Leukemia by Application (2021–2032)
Figure 58. Global Targeted Therapy Drugs for Leukemia Price (US$/Unit) by Application (2021–2032)
Figure 59. Targeted Therapy Drugs for Leukemia Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
